目的探讨由动员人外周造血祖细胞体外培养扩增获得的树突状细胞(DC)的生物学特性，为临床应用肿瘤树突状细胞疫苗建立制备方法。
Objective to obtain dendritic cells (DCs) from peripheral blood stem cells and hematopoietic precursor cells in vitro, and assess the feasibility of clinical application of tumor vaccine.
目的探讨由动员人外周造血祖细胞体外培养扩增获得的树突状细胞(DC)的生物学特性，为临床应用肿瘤树突状细胞疫苗建立制备方法。
Objective to obtain dendritic cells (DCs) from peripheral blood stem cells and hematopoietic precursor cells in vitro, and assess the feasibility of clinical application of tumor vaccine.
应用推荐